Information Provided By: 
Fly News Breaks for April 9, 2015
ICPT
Apr 9, 2015 | 08:20 EDT
Wedbush analyst Liana Moussatos points out that Intercept is expected to present two late-breaking presentations at the European Association for the Study of the Liver, which is taking place April 22-26 in Vienna, Austria. Moussatos thinks the presentations will further support the benefits of Intercept's OCA for the treatment of nonalcoholic steatohepatitis. The analyst reiterates an Outperform rating on the drug maker with a $493 per share acquisition value. Shares of Intercept closed yesterday up $5.18 to $272.85.
News For ICPT From the Last 2 Days
There are no results for your query ICPT
